Scarica l'app Stockscreener
0.68
2.86%
-0.02
Precedente Chiudi:
$0.70
Aprire:
$0.7004
Volume 24 ore:
52,887
Relative Volume:
0.42
Capitalizzazione di mercato:
$15.10M
Reddito:
$137.00K
Utile/perdita netta:
$-24.37M
Rapporto P/E:
-0.4575
EPS:
-1.4862
Flusso di cassa netto:
$-15.97M
1 W Prestazione:
-11.92%
1M Prestazione:
-23.01%
6M Prestazione:
-27.66%
1 anno Prestazione:
-37.04%
Intervallo 1D:
$0.68
$0.735
Intervallo di 1 settimana:
$0.68
$0.7999
Portata 52W:
$0.68
$2.582
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
Nome
Adagio Medical Holdings Inc
Settore
Industria
Telefono
(949) 348-1188
Indirizzo
26051 MERIT CIRCLE, LAGUNA HILLS
Compare ADGM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADGM
Adagio Medical Holdings Inc
|
0.68 | 15.10M | 137.00K | -24.37M | -15.97M | -1.4862 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adagio Medical Holdings Inc Stock (ADGM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-14 | Iniziato | Piper Sandler | Overweight |
| 2025-12-02 | Iniziato | Lake Street | Buy |
Adagio Medical Holdings Inc Borsa (ADGM) Ultime notizie
Adagio Medical Holdings Inc (ADGM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Adagio Medical Holdings Inc (ADGM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Adagio Medical Holdings Inc (ADGM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Adagio Medical Holdings Inc (ADGM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Adagio Medical Holdings Inc (ADGM) Institutional Confidence - TradingKey
Adagio Medical Holdings Inc (ADGM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Adagio Medical Holdings Inc - TradingKey
Adagio Medical Holdings Inc (ADGM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Adagio Medical Holdings Inc (ADGM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adagio Medical Advances VT Cryoablation Study, Setting Up a New Cardiac Device Catalyst - TipRanks
Adagio Medical Receives IDE Approval to Investigate Next-Gen vCLAS Ventricular Ablation System - Medical Product Outsourcing
Adagio Medical Holdings, Inc. 8-K Filing: 2026 Annual Meeting Results & Company Details - Minichart
Adagio Medical Holdings elects directors and ratifies auditor at annual meeting - Investing.com Nigeria
Adagio Medical Shareholders Approve Directors and Auditor Ratification - TipRanks
Adagio Medical (NASDAQ: ADGM) posts 2026 director and auditor vote outcomes - Stock Titan
ADGM: Directors and auditor ratified with no shareholder questions; results to be filed on Form 8-K - TradingView
ADGM: Directors and auditor were approved by shareholders, with no questions raised - TradingView
ADGM Q1 2026 Earnings: EPS Miss Amid Pre-Revenue Status; Stock Declines 3.5%ROE Trend Analysis - newsline.com
Adagio Medical receives Nasdaq notice for minimum bid price non-compliance - Investing.com Canada
Adagio Medical receives Nasdaq notice for minimum bid price non-compliance By Investing.com - Investing.com Australia
Adagio Medical Faces Nasdaq Minimum Bid Price Noncompliance - TipRanks
ADGM Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesSurprise Factor Analysis - newsline.com
Adagio Medical Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Adagio Medical (NASDAQ: ADGM) flagged by Nasdaq for sub-$1 bid price and faces delisting risk - Stock Titan
ADGM Q1 2026 Earnings: Wider Loss Misses Estimates as Pre-Revenue Stage ContinuesQuarterly Earnings Report - newsline.com
ADGM Q1 2026 Earnings: EPS Misses Estimates as Losses Widen; No Revenue YetEarnings Preview - newsline.com
Adagio Medical Holdings Inc (ADGM) Q1 2026 Earnings: EPS Miss Exacerbates Investor Concerns as Pre-Revenue Company Confronts Cash BurnProfit Guidance Range - newsline.com
Adagio Medical Holdings (ADGM) Dips 3.3% as Shares Test Key Support at $0.68New Listing Stocks - newsline.com
ADGM Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage ContinuesGuidance Accuracy Score - newsline.com
Lucid Capital Markets initiates Adagio Medical stock with buy rating - Investing.com UK
ADGM Initiates Coverage On LUCID CAPITAL MARKETS -- Rating Set t - GuruFocus
Number of shareholders of Adagio Medical Holdings, Inc – NASDAQ:ADGM - TradingView
Lucid Capital Markets initiates Adagio Medical stock with buy rating By Investing.com - Investing.com Canada
Adagio Medical Seeks FDA OK for Heart Device - Orange County Business Journal
ADGM Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue OperationsRevenue Inflection Point - newsline.com
Adagio Medical Holdings (ADGM) Holds Near Support After Marginal DeclineRounding Bottom - newsline.com
Adagio Medical Holdings (ADGM) Holds Steady Near $0.72 as Trading Volume Remains SubduedNews Sentiment - newsline.com
Adagio Medical’s vCLAS System Used to Treat Premature Ventricular Contractions - Medical Product Outsourcing
ADGM Q1 2026 Earnings: EPS Misses Estimates, Shares Slide 10.8%Revenue Inflection Point - newsline.com
ADGM - Finviz
Adagio Medical Holdings (ADGM) Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Development CostsProfitability Analysis - newsline.com
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - BioSpace
Adagio Files PMA for Breakthrough Ventricular Ablation System - TipRanks
Adagio Medical (ADGM) files FDA PMA for vCLAS ventricular tachycardia ablation system - Stock Titan
Adagio Medical submits FDA application for VT ablation system By Investing.com - Investing.com Nigeria
Adagio Medical submits FDA application for ventricular tachycardia ablation system - Medical Economics
Adagio Medical submits FDA application for VT ablation system - Investing.com
Adagio Medical submits premarket approval application to FDA for Vclas® ventricular ablation system - marketscreener.com
First purpose-built VT ablation system heads to FDA after 84% shock-free trial - Stock Titan
Adagio Medical Holdings' US$2.5m Market Cap Fall Books Insider Losses - Sahm
Perceptive Advisors (NASDAQ: ADGM) discloses 55.4% stake via Schedule 13G/A - Stock Titan
Adagio Medical Holdings Inc Azioni (ADGM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Adagio Medical Holdings Inc Azioni (ADGM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Usen Todd | Chief Executive Officer |
Dec 12 '25 |
Buy |
1.09 |
207,315 |
225,973 |
207,315 |
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):